These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2964112

  • 1. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
    Bowes LG, Dumble LJ, Clunie GJ, Francis DM, Macdonald IM, Kincaid-Smith P.
    Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
    [No Abstract] [Full Text] [Related]

  • 2. Increased frequency of kidney allograft rejection in recipients with cyclosporine and/or steroid-resistant lymphoid responses.
    Bowes LG, Dumble LJ, Francis DM, Macdonald IM, Clunie GJ, Kincaid-Smith P.
    Transplant Proc; 1990 Oct; 22(5):2139-40. PubMed ID: 2145672
    [No Abstract] [Full Text] [Related]

  • 3. Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses.
    Bowes LG, Dumble LJ, Clunie GJ, Francis DM, Macdonald IM, Kincaid-Smith P.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1470-1. PubMed ID: 2523587
    [No Abstract] [Full Text] [Related]

  • 4. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI, Tannenbaum GA, Cohen DJ, Appel G, Hardy MA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract] [Full Text] [Related]

  • 5. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM, Bas J, Gonzalez C, Castelao AM, Seron D, Mestre M, Buendia E, Sabate R, Diaz C, Alsina J.
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract] [Full Text] [Related]

  • 6. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
    Dunn JF, Hatch J, Precht A, Hart M, Li S.
    Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
    [No Abstract] [Full Text] [Related]

  • 7. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
    Tellis VA, Matas AJ, Quinn TA, Glicklich D, Weiss RJ, Soberman RJ, Veith FJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
    [No Abstract] [Full Text] [Related]

  • 8. Cyclosporine as initial treatment for first acute rejection episodes in renal transplantation.
    Novick AC, Steinmuller D, Ho-Hsieh H, Streem SB, Cunningham R, Steinhilber D, Buszta C.
    Transplant Proc; 1986 Jun; 18(3 Suppl 2):19-21. PubMed ID: 3520999
    [No Abstract] [Full Text] [Related]

  • 9. Rabbit anti-thymocyte globulin treatment of steroid resistant rejection in renal allograft recipients immunosuppressed with cyclosporine A.
    O'Donoghue DJ, Johnson RW, Mallick NP, Gokal R, Ballardie FW, Bakran A, Pearson R, Scott P.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1736-7. PubMed ID: 2652568
    [No Abstract] [Full Text] [Related]

  • 10. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppression in kidney transplantation].
    Grundmann R, Pichlmaier H.
    Dtsch Med Wochenschr; 1983 May 06; 108(18):687-9. PubMed ID: 6341031
    [No Abstract] [Full Text] [Related]

  • 13. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J, Masramon J, Orfila A, Cuevas X, Aubia J.
    Transplant Proc; 1987 Feb 06; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract] [Full Text] [Related]

  • 14. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY, Zemel SM, Weir MR, Dagher FJ, Bentley FR.
    Transplant Proc; 1987 Feb 06; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract] [Full Text] [Related]

  • 15. [Prevention of graft rejection--preoperative blood transfusion and use of immunosuppressive agents].
    Kashiwabara H.
    Nihon Rinsho; 1985 Jan 06; 43(1):37-40. PubMed ID: 3886961
    [No Abstract] [Full Text] [Related]

  • 16. Immunosuppression in cardiac transplantation.
    Rose EA, Addonizio LJ.
    Bibl Cardiol; 1988 Jan 06; (43):1-9. PubMed ID: 3067706
    [No Abstract] [Full Text] [Related]

  • 17. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U, Frei D, Keusch G, Burger HR, Largiader F, Binswanger U.
    Transplant Proc; 1988 Oct 06; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract] [Full Text] [Related]

  • 18. Use of ATG for reversal of acute allograft rejection.
    Nowygrod R, Appel G, Hardy MA.
    Transplant Proc; 1981 Mar 06; 13(1 Pt 1):469-72. PubMed ID: 7022875
    [No Abstract] [Full Text] [Related]

  • 19. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy.
    Lundgren G, Fehrman I, Gunnarsson R, Lindholm B, Tillegård A, Ost L, Groth CG.
    Transplant Proc; 1982 Sep 06; 14(3):601-4. PubMed ID: 6758244
    [No Abstract] [Full Text] [Related]

  • 20. Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.
    Hoitsma AJ, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Oct 06; 20(5 Suppl 6):12-3. PubMed ID: 3051578
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.